IDO1 and endometrial cancer: In the present study, we demonstrated the expression of the tryptophan-catabolising and immunosuppressive enzyme, IDO, in endometrial cancer using 80 surgical specimens, and found that the high IDO expression by tumour cells was positively correlated with disease progression and the impaired patient survival.